HOME
| Logistics firm launches centre of excellence in Northants |
| Written by Lautaro Vargas | |
| Wednesday, 12 December 2007 | |
 RF temperature controls enhance NYK’s pharma storage facility Equipped with state-of-the-art hard and software, the strategically located facility underpins NYK’s ability to offer quality assured, high-security supply chain solutions, allowing customers to focus on their core R & D, manufacturing and marketing activities. Part of NYK’s flagship distribution complex in Northampton, the 175,000 sq ft, Medicines and Healthcare products Regulatory Agency-licensed facility has been converted into a purpose-built 1,000 pallet cold store with an additional 16,000 pallets in temperature-controlled ambient (temperate) storage. To maintain a temperature between 2°-8°C in the cold store and between 8°-25°C through the remainder of the site, the whole facility is equipped with the latest temperature control and monitoring equipment. Forty six Radio Frequency transmitters have been located throughout the facility, in order to monitor the temperature continuously. The system relays temperature data into a base station, which is linked to a fully networked computer system that can be accessed remotely. As well as audible alarms, warning messages are sent automatically to managers’ mobile phones should the temperatures deviate from the required settings. The facility is also fully equipped with an emergency spillage area and staff have received emergency response training, as well as specialist training in the use of equipment, including respirators. General manager Larry Walsh said: “Pharmaceutical manufacturers are increasingly concentrating on core R & D, manufacturing and marketing activities and entrusting their storage and distribution to specialist third parties such as NYK. “For obvious reasons, the pharmaceutical industry is heavily regulated, with both manufacturers and their suppliers being required to demonstrate adherence to strict quality, safety and security procedures. “The investment in GP3 underpins our ability to do this and our commitment to the pharmaceutical sector and will allow us to continue to build on our experience of working with major pharmaceutical manufacturers.” Earlier this year, NYK landed a £6 million contract with one of the world’s leading pharmaceuticals, AstraZeneca, to handle its primary distribution needs for its European pharmaceutical products. Though centred in Milton Keynes, it was NYK’s pan-European pharmaceutical network, an established centralised planning hub, understanding of the pharmaceutical supply chain and track record in delivering continuous improvement that persuaded AZ to make NYK its sole distribution operator in Europe. NYK Logistics is a global provider of integrated supply chain solutions, offering a combination of services, supported by sea, air, road and rail resources and a worldwide network of over 110 large-scale storage, consolidation and distribution centres. Supported by the £8 billion NYK group, the company has developed a wide range of supply chain expertise by working with blue chip clients within the fmcg, retail, consumer electronics, grocery, apparel, automotive and pharmaceutical sectors around the world.
Set as favorite
Bookmark
Email This
Hits: 917 Trackback(0)
Comments (0)
 Write comment
This content has been locked. You can no longer post any comment.
|
TrackBack URI for this entry
Subscribe to this comment's feed
Show/Hide comments
Show/Hide comment form
Delicious
Digg
NewsVine
Reddit
Technorati| < Prev |
|---|
|
|
 |